Astec LifeSciences Limited (NSE:ASTEC)

Market Cap	13.98B -21.4%
Revenue (ttm)	4.09B -1.7%
Net Income	-892.48M
EPS	-43.02
Shares Out	22.28M
PE Ratio	n/a
Forward PE	105.92
Dividend	n/a
Ex-Dividend Date	n/a

Volume	17,852
Average Volume	42,290
Open	633.50
Previous Close	632.85
Day's Range	625.00 - 641.50
52-Week Range	554.00 - 998.40
Beta	-0.30
RSI	48.67
Earnings Date	Apr 24, 2026

About Astec LifeSciences

Astec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. The company provides triazole fungicides for use in field crops; foliar treatment for the control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservative. It also provides herbicides, insec...

• Industry: Agricultural Inputs
• Sector: Materials
• Founded: 1994
• Employees: 555
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ASTEC

Financial Performance

In fiscal year 2025, Astec LifeSciences's revenue was 3.81 billion, a decrease of -16.86% compared to the previous year's 4.59 billion. Losses were -1.35 billion, 187.1% more than in 2024.